Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6775 USD | +2.09% |
|
+0.24% | -49.81% |
Jul. 09 | Athyrium Capital Management Engages in Discussions with Biora Therapeutics Inc | CI |
Jul. 01 | Biora Therapeutics, Inc. Announces Positive Clinical Trial Results for BT-600 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.81% | 24.35M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- BIOR Stock
- News Biora Therapeutics, Inc.
- Biora Therapeutics Says FDA Cleared Application for Investigational Ulcerative Colitis Treatment; Shares Rise Pre-Bell